Thornburg Investment Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
BG
Thornburg Investment Management's AMED Position: Q2 2022 in Review
Thornburg Investment Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 90,516 shares — an estimated $15.6M sold.
Thornburg Investment Management first reported a position in AMED in Q4 2020 and held it in 6 quarters. The position peaked at $34.6M in Q1 2021. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.
- Thornburg Investment Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
- Thornburg Investment Management sold 90,516 Amedisys shares in Q2 2022, an estimated $15.6M.
- Thornburg Investment Management first reported a position in Amedisys in Q4 2020 and held it in 6 quarters.
- Thornburg Investment Management's Amedisys position peaked at $34.6M in Q1 2021.
- 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.
Based on Thornburg Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.